Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Plant-derived biflavonoid with antiinflammatory activity

Dec. 4, 1997

Results of IDEC-151/SB-217969 phase I trial reported

Dec. 4, 1997

S-2474: antiarthritic agent with dual NSAID/DMARD profile

Dec. 4, 1997

Amarillo reports positive phase II data in Sjogren's syndrome trial

Dec. 3, 1997

Almirall discloses new COX-2-selective compounds

Dec. 2, 1997

Teva receives FDA approval for generic etodolac

Dec. 1, 1997

JT licenses new oral antiinflammatory agent to R.W. Johnson

Nov. 26, 1997

Anika signs Orthovisc marketing agreement with Zimmer

Nov. 25, 1997

InKine (formerly Panax) completes acquisitions, raises funds for CBP-1011 development

Nov. 21, 1997

Collagenase treatment for Dupuytren's disease enters phase II

Nov. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...